Carlo Perno to Administration, Oral
This is a "connection" page, showing publications Carlo Perno has written about Administration, Oral.
Connection Strength
0.050
-
Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study. J Antimicrob Chemother. 2017 Dec 01; 72(12):3420-3424.
Score: 0.026
-
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens. PLoS One. 2017; 12(5):e0177352.
Score: 0.025